Pfizer and BioNTech say their COVID-19 vaccine is over 90% effective

Pfizer Inc said on Monday its experimental COVID-19 vaccine was more than 90% effective, a major victory in the fight against a pandemic that has killed more than a million people, battered the world's economy and upended daily life.

Instant view: Pfizer, BioNTech say their COVID-19 vaccine is more than 90% effective

Pfizer Inc said on Monday its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large study, a major victory in the fight against the pandemic.

China holds off on sending congratulations to Biden

China, which has held off on congratulating U.S. presidential election winner Joe Biden even as leaders of other countries have done so, said on Monday it would follow custom in responding to the result.

Merkel, after Biden victory, says EU and U.S. must work side by side

German Chancellor Angela Merkel on Monday congratulated U.S. President-elect Joe Biden on his election and called for the European Union and United States to work "side by side", but also acknowledged the EU must do more to take care of its own security.

Sanofi believes Europe better prepared to address pandemics

Sanofi's Chief Executive Paul Hudson said on Monday Europe was better prepared than it was previously to ensure a COVID-19 vaccine reaches the population as well as when it came to addressing future pandemics.

Q&A: Where are we in the COVID-19 vaccine race?

Drugmakers and research centers around the world are working on COVID-19 vaccines, with large global trials of several of the candidates involving tens of thousands of participants well underway.

Sanofi continues to enroll patients for other diseases treatment: CEO

French drugmaker Sanofi continues to enroll patients for the treatment of diseases other than COVID-19 and maintains a 100% capacity to manufacture drugs, its chief executive said on Monday.

Sanofi has narrowed gap vs competitors in development of COVID-19 vaccine, CEO says

French drugmaker Sanofi has narrowed the gap against its rivals in the development of a COVID-19 vaccine, its Chief Executive said on Monday.

Germany expects COVID-19 vaccine in first quarter 2021 at the earliest

Germany does not expect a coronavirus vaccine to be available before the first quarter of 2021, according to its national vaccine strategy seen by Reuters on Monday, as experts presented guidelines on who should be first-in-line for the shots.

Swiss report 17,309 new coronavirus cases over three days

Coronavirus infections rose by 17,309 cases since Friday, data from Swiss health authorities showed on Monday.

Utah governor declares new state of emergency as coronavirus spreads

The governor of the U.S. state of Utah, Gary Herbert, declared late on Sunday a new state of emergency to address hospital overcrowding in response to weeks of stress on its hospital networks due to a surge of novel coronavirus cases.

Related Videos

Remdesivir shunned in WHO-led COVID study

Biogen Alzheimer's drug closer to approval

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS